Medical DevicesTechnology

Gastric Bypass Edges Lap-band and Sleeve Gastrectomy in Outcomes

1 Mins read

Two recent reports in the Archives of Surgery (Arch Surg. 2011;146[2]:143-148, 149-155) indicate that, in the treatment of moderately to morbidly obese patients, while gastric bypass surgery has a comparable rate of complications as lap-band and sleeve gastrectomy, it has a lower rate of re-operations needed, results in better long-term weight loss and better outcomes associated with type 2 diabetes. Although the authors of the two studies are careful to note that additional research is necessary to both confirm these results and elucidate the reasons behind the different outcomes, the lowered risk of complications combined with better apparent outcomes will temper the rate of adoption of lap-band usage that was poised to accelerate as a result of the FDA’s recent decision to expand the use of lap-band for patients with lower body mass indices (BMI). Obesity is the subject of intense focus, in clinical practice and medical technology, since it carries high costs in the healthcare systems, directly and indirectly (through co-morbidities like diabetes and heart disease, among many others). Treatment of obesity now includes a range of medical and surgical options:

  • Drugs
    • Satiety
    • Malabsorption
    • Appetite suppression
    • Combination drugs
  • Medical devices
    • Restrictive
    • Artificial fullness
    • Malabsorption
    • Gastric emptying
    • Appetite suppression

For more information on obesity treatment markets, see MedMarket Diligence, LLC, Report #S835, “Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019” (published February 2011).

183 posts

About author
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses. Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.
Related posts
Policy & LawTechnology

The Rising Importance of Data Governance and Archiving in Healthcare

3 Mins read
One of the biggest challenges for healthcare organizations, especially as they become more digital, is managing sensitive patient information. With stricter regulations…
eHealthMobile HealthTechnology

Technologies That Can Help You Keep Track of Your Health

3 Mins read
Here and now in the digital age, technology plays a vital role in nearly every part of life. Because maintaining a healthy…
Health careTechnologyTelemedicine

How Telehealth and 5G are Transforming Healthcare?

3 Mins read
When we talk about ‘Innovation’s Cusp’, healthcare is surely at the top as always. This is because there is tremendous room for…